Fostera PCV MHThis page contains information on Fostera PCV MH for veterinary use.
The information provided typically includes the following:
- Fostera PCV MH Indications
- Warnings and cautions for Fostera PCV MH
- Direction and dosage information for Fostera PCV MH
Fostera PCV MHThis treatment applies to the following species:
Porcine Circovirus Vaccine, Type 1-Type 2 Chimera
Mycoplasma Hyopneumoniae Bacterin
For vaccination of healthy pigs 3 weeks of age or older as an aid in preventing viremia, lymphoid depletion, and colonization of lymphoid tissue caused by porcine circovirus type 2; and as an aid in reducing PCV2 virus shedding and enzootic pneumonia caused by M. hyopneumoniae. A 23-week duration of immunity has been demonstrated against PCV2. M. hyopneumoniae duration-of-immunity studies are in progress.
Directions For Use
Shake well. Aseptically administer a single 2-mL dose intramuscularly. Fostera PCV/MH may also be given as two 1-mL doses administered 2 weeks apart.
PrecautionsStore at 2°-7°C (35°-45°F). Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Contains gentamicin and thimerosal as preservatives. Allergic reactions, although rare, may occur. The antidote is epinephrine.
For Veterinary Use Only
Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).
U.S. Veterinary License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
NAC No.: 3690374.2
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Fostera PCV MH information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-05-31